San Francisco Sentry Investment Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-550
Closed -$13K 893
2018
Q2
$13K Sell
550
-5,750
-91% -$119K 0.01% 546
2018
Q1
$100K Hold
6,300
0.03% 366
2017
Q4
$131K Buy
6,300
+1,900
+43% +$30.1K 0.04% 321
2017
Q3
$63K Buy
4,400
+400
+10% +$6.05K 0.02% 391
2017
Q2
$69K Buy
+4,000
New +$47.9K 0.02% 325
2014
Q4
Sell
-350
Closed -$46K 185
2014
Q3
$46K Hold
350
0.02% 307
2014
Q2
$44K Hold
350
0.02% 329
2014
Q1
$46K Buy
+350
New +$47.9K 0.01% 365

Other funds holding BHC

San Francisco Sentry Investment Group's BHC Position: Q3 2018 in Review

San Francisco Sentry Investment Group sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 550 shares — an estimated $13K sold.

San Francisco Sentry Investment Group first reported a position in BHC in Q1 2014 and held it in 8 quarters. The position peaked at $131K in Q4 2017. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • San Francisco Sentry Investment Group reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 550 Bausch Health shares in Q3 2018, an estimated $13K.
  • San Francisco Sentry Investment Group first reported a position in Bausch Health in Q1 2014 and held it in 8 quarters.
  • San Francisco Sentry Investment Group's Bausch Health position peaked at $131K in Q4 2017.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q3 2018, filed 9 Nov 2018.